CLO25-072: A Multicenter, Randomized, Controlled, Non-Inferiority Study of Narlumosbart Compared with Denosumab in the Treatment of Bone Disease in Patients with Multiple Myeloma.
Journal of the National Comprehensive Cancer Network JNCCN(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined